These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 12742556

  • 41. Comparative study of the therapeutic effects of oral contraceptive pills containing desogestrel, cyproterone acetate, and drospirenone in patients with polycystic ovary syndrome.
    Bhattacharya SM, Jha A.
    Fertil Steril; 2012 Oct; 98(4):1053-9. PubMed ID: 22795636
    [Abstract] [Full Text] [Related]

  • 42. Changes in serum apo-lipoprotein AI and sex-hormone-binding globulin levels after treatment with two different progestins administered alone and in combination with ethinyl estradiol.
    Crona N, Silfverstolpe G, Samsioe G.
    Contraception; 1984 Mar; 29(3):261-70. PubMed ID: 6234148
    [Abstract] [Full Text] [Related]

  • 43. Effects of oral contraceptive combinations containing levonorgestrel or desogestrel on serum proteins and androgen binding.
    Bergink EW, Holma P, Pyörälä T.
    Scand J Clin Lab Invest; 1981 Nov; 41(7):663-8. PubMed ID: 6461916
    [Abstract] [Full Text] [Related]

  • 44. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen.
    Bloemenkamp KW, Rosendaal FR, Helmerhorst FM, Büller HR, Vandenbroucke JP.
    Lancet; 1995 Dec 16; 346(8990):1593-6. PubMed ID: 7500751
    [Abstract] [Full Text] [Related]

  • 45. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
    Palatsi R, Hirvensalo E, Liukko P, Malmiharju T, Mattila L, Riihiluoma P, Ylöstalo P.
    Acta Derm Venereol; 1984 Dec 16; 64(6):517-23. PubMed ID: 6084924
    [Abstract] [Full Text] [Related]

  • 46. Two oral contraceptives, efficacy, serum proteins, and lipid metabolism. A comparative multicentre study on a triphasic and a fixed dose combination.
    Cullberg G, Samsioe G, Andersen RF, Bredesgaard P, Andersen NB, Ernerot H, Fanøe E, Fylling P, Haack-Sørensen PE, Klottrup P, Pedersen JH, Sandager T.
    Contraception; 1982 Sep 16; 26(3):229-43. PubMed ID: 6217028
    [Abstract] [Full Text] [Related]

  • 47. Comparative profiles of reliability, cycle control and side effects of two oral contraceptive formulations containing 150 micrograms desogestrel and either 30 micrograms or 20 micrograms ethinyl oestradiol.
    Akerlund M, Røde A, Westergaard J.
    Br J Obstet Gynaecol; 1993 Sep 16; 100(9):832-8. PubMed ID: 8218004
    [Abstract] [Full Text] [Related]

  • 48. Pharmacokinetics of levonorgestrel and ethinylestradiol in 14 women during three months of treatment with a tri-step combination oral contraceptive: serum protein binding of levonorgestrel and influence of treatment on free and total testosterone levels in the serum.
    Kuhnz W, Staks T, Jütting G.
    Contraception; 1994 Dec 16; 50(6):563-79. PubMed ID: 7705098
    [Abstract] [Full Text] [Related]

  • 49. The effect of monophasic combinations of ethinyl estradiol and norethindrone on gonadotropins, androgens and sex hormone binding globulin: a randomized trial.
    Moutos D, Smith S, Zacur H.
    Contraception; 1995 Aug 16; 52(2):105-9. PubMed ID: 8536446
    [Abstract] [Full Text] [Related]

  • 50. Treatment of hirsutism with ethinyl estradiol-desogestrel contraceptive pills has beneficial effects on the lipid profile and improves insulin sensitivity.
    Escobar-Morreale HF, Lasunción MA, Sancho J.
    Fertil Steril; 2000 Oct 16; 74(4):816-9. PubMed ID: 11020530
    [Abstract] [Full Text] [Related]

  • 51. Treatment of hirsutism with flutamide and a low-dosage oral contraceptive in polycystic ovarian disease patients.
    Ciotta L, Cianci A, Marletta E, Pisana L, Aglianò A, Palumbo G.
    Fertil Steril; 1994 Dec 16; 62(6):1129-35. PubMed ID: 7957975
    [Abstract] [Full Text] [Related]

  • 52. Influence of gestodene and desogestrel as components of low-dose oral contraceptives on the pharmacokinetics of ethinyl estradiol (EE2), on serum CBG and on urinary cortisol and 6 beta-hydroxycortisol.
    Hammerstein J, Daume E, Simon A, Winkler UH, Schindler AE, Back DJ, Ward S, Neiss A.
    Contraception; 1993 Mar 16; 47(3):263-81. PubMed ID: 8462317
    [Abstract] [Full Text] [Related]

  • 53. Effect of low-dose oral contraceptives on androgenic markers and acne.
    Thorneycroft IH, Stanczyk FZ, Bradshaw KD, Ballagh SA, Nichols M, Weber ME.
    Contraception; 1999 Nov 16; 60(5):255-62. PubMed ID: 10717776
    [Abstract] [Full Text] [Related]

  • 54. Effects of a low-dose desogestrel-ethinylestradiol combination on hirsutism, androgens and sex hormone binding globulin in women with a polycystic ovary syndrome.
    Cullberg G, Hamberger L, Mattsson LA, Mobacken H, Samsioe G.
    Acta Obstet Gynecol Scand; 1985 Nov 16; 64(3):195-202. PubMed ID: 3160211
    [Abstract] [Full Text] [Related]

  • 55. Effect of second- and third-generation oral contraceptives on fibrinolysis in the absence or presence of the factor V Leiden mutation.
    Kemmeren JM, Algra A, Meijers JC, Bouma BN, Grobbee DE.
    Blood Coagul Fibrinolysis; 2002 Jul 16; 13(5):373-81. PubMed ID: 12138364
    [Abstract] [Full Text] [Related]

  • 56. Effects on acne of two oral contraceptives containing desogestrel and cyproterone acetate.
    Charoenvisal C, Thaipisuttikul Y, Pinjaroen S, Krisanapan O, Benjawang W, Koster A, Doesburg W.
    Int J Fertil Menopausal Stud; 1996 Jul 16; 41(4):423-9. PubMed ID: 8894800
    [Abstract] [Full Text] [Related]

  • 57. Comparison of two oral contraceptives containing either drospirenone or cyproterone acetate in the treatment of hirsutism.
    Batukan C, Muderris II, Ozcelik B, Ozturk A.
    Gynecol Endocrinol; 2007 Jan 16; 23(1):38-44. PubMed ID: 17484511
    [Abstract] [Full Text] [Related]

  • 58. Risk of idiopathic cardiovascular death and nonfatal venous thromboembolism in women using oral contraceptives with differing progestagen components.
    Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C.
    Lancet; 1995 Dec 16; 346(8990):1589-93. PubMed ID: 7500750
    [Abstract] [Full Text] [Related]

  • 59. Changes in coagulation and anticoagulation in women taking low-dose triphasic oral contraceptives: a controlled comparative 12-month clinical trial.
    Notelovitz M, Kitchens CS, Khan FY.
    Am J Obstet Gynecol; 1992 Nov 16; 167(5):1255-61. PubMed ID: 1442974
    [Abstract] [Full Text] [Related]

  • 60. Clinical and hormonal effects of the combination gonadotrophin-releasing hormone agonist plus oral contraceptive pills containing ethinyl-oestradiol (EE) and cyproterone acetate (CPA) versus the EE-CPA pill alone on polycystic ovarian disease-related hyperandrogenisms.
    Acién P, Mauri M, Gutierrez M.
    Hum Reprod; 1997 Mar 16; 12(3):423-9. PubMed ID: 9130733
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.